<DOC>
	<DOCNO>NCT02491333</DOCNO>
	<brief_summary>The objective randomize control trial compare insulin sensitivity follow true acupuncture + placebo metformin ( Group 1 ) v sham acupuncture + placebo metformin ( Group 2 ) v sham acupuncture + metformin ( Group 3 ) woman PCOS IR .</brief_summary>
	<brief_title>The RCT Acupuncture PCOS Combined With IR</brief_title>
	<detailed_description>1.1 Study design This randomize double blind control . 1.2 Subject selection exclusion Women PCOS IR recruit Department Traditional Chinese Medicine first affiliate hospital Guangzhou Medical University , Xuzhou maternity &amp; child health hospital , Liwan hospital traditional Chinese medicine , Hexian memorial affiliate hospital Southern Medical University meet inclusion criterion exclusion criterion . Eligible subject approach sign consent form detail explanation study design comprehensive counseling . 1.3 Screening visit Women screen morning overnight 12 hour fast . Detailed information study design give . 1.3.1 Sign inform consent Informed consent sign detailed counseling . 1.3.2 Perform physical examination Perform complete physical examination include height , weight , hip , waist measurement . Height weight record near 0.1 cm 0.1 kg respectively . Waist hip circumference record near 1 cm . And assessment hirsutism FG , acne standard acne lesion count , pelvic exam . 1.3.3 Perform transvaginal ultrasound ovary Ovaries , include ovarian size three dimension , size large ovarian follicle/cyst size every follicle mean diameter great 10 mm , total antral follicle count ( small follicle mean diameter &lt; 10 mm ) ovary obtain transvaginal ultrasound . 1.3.4 Check urine pregnancy test 1.3.5 Fasting blood sample exclude endocrine disorder Fasting ( least 4 h ) blood sample take exclude endocrine disorder : F-glucose , F-insulin , Hba1C ( &gt; 7 % ) , C-peptide , TSH ( &lt; 0.2 mIU/mL &gt; 5.5 mIU/mL ) , T3 ( &lt; 1.4 nmol/L &gt; 2.2nmol/L ) , free T4 ( &lt; 10pmol/L &gt; 23pmol/L ) . 1.3.6 Progestin withdrawal Prescribe progestin induce withdrawal bleed , eligibility determine . 1.4 Baseline visit After screen visit , woman fulfills inclusion criterion sign informed consent assign baseline visit . Baseline visit take place day 2 - 5 spontaneous period withdrawal bleed overnight fast . 1.4.1 Laboratory Examination Collect 20ml blood , 10ml blood follow test . The remain 10ml blood store determination DNA sphingolipid later . 1 . Circulating sex steroid : Fasting serum level follicle-stimulating hormone ( FSH ) , luteinizing hormone ( LH ) , estrogen ( E2 ) , prolactin ( PRL ) T , sex hormone bind globulin ( SHBG ) , dehydroepiandrosterone sulfate ( DHEAS ) . 2 . Lipid profile : Triglycerides ( TG ) , total cholesterol ( TC ) , high density lipoprotein ( HDL-C ) , low density lipoprotein ( LDL-C ) , apolipoprotein A1 ( Apoa1 ) , apolipoprotein B ( ApoB ) , BRT , Renal , Liver Profile . 3 . Glucose homeostasis : The oral glucose tolerance test ( OGTT ) 75 g glucose . Blood sample obtain measure plasma glucose , serum insulin C-peptide 0 , 60 , 120 min OGTT . 1.4.2 Complete questionnaire Quality life assess short form 36 ( SF-36 ) , Chinese Quality Life ( ChiQOL ) , sleep questionnaire , international physical activity questionnaire ( IPAQ ) Polycystic Ovary Syndrome Questionnaire ( PCOS-QOL ) . Investigators also assess symptom anxiety depression Zung SAS Zung SDS questionnaire . And complete quantization table traditional Chinese medicine ( TCM ) syndromes PCOS . 1.4.3 Assess TCM syndromes patient Syndrome differentiation ( Bian Zheng ) TCM comprehensive analysis clinical information gain four main diagnostic TCM procedure : observation , listen , question , pulse analysis , use guide choice treatment either acupuncture and/or TCM herbal formula . In PCOS , patient empirically differentiate four category : 1 ) phlegm-dampness syndrome , 2 ) blood stasis syndrome , 3 ) phlegm , 4 ) blood stasis . 2 . Intervention arm 2.1 Information study subject All participant advise importance regular physical exercise balance diet trained dietician . Importantly , instructed change exercise diet habit entire study period . True acupuncture , sham acupuncture metformin/placebo start 2 day baseline visit include OGTT . All subject ask use barrier method contraception . True sham acupuncture treatment give three time per week . Each treatment session last 30 minute separate interval 1-3 day , maximum 90 treatment session 4 month . After third treatment , patient fill expectation credibility questionnaire . Metformin placebo give 0.5g/times , 3 time one day 4 month . 2.1.1 True acupuncture protocol The rationale acupuncture protocol base Western Medical theory study protocol follow CONSORT STRICTA recommendations.Investigators use fixed acupuncture protocol . The acupuncture protocol RCT follow protocol follow study : ClinicalTrial.gov NCT01457209 NCT02026323 . Disposable , single-use , sterilize needle make stainless steel , 0.25 x 30 mm 0.30 x 40/50 mm ( Hwoto , Suzhou Medical Appliance Fact . 215005 Suzhou , China ) insert depth 15-35 mm segmental acupuncture point locate abdominal leg muscle innervation correspond ovary . Two set acupuncture point alternate every second treatment . The first set consist conception vessel ( CV ) 4 , CV 12 , stomach ( ST ) 29 bilaterally muscle knee , ST 34 , ST 32 bilaterally knee , spleen ( SP ) 6 ST 36 . Needles also place extra segmental acupuncture point innervate ovary large intestine ( LI ) 4 bilaterally . In total 14 needle place stimulate manually rotate needle evoke needle sensation ( de qi ) insert . The following point connect electrical stimulator ( Export Abteilung , Schwa-Medico GmbH , Wetzlarer Str . 41-43 ; 35630 Ehringshausen ) : CV 4 CV 12 , ST 29 bilateral , ST34 ST 32 bilateral . Stimulation give low-frequency EA 2Hz , 0.3 m pulse length intensity adjust produce local muscle contraction without pain discomfort . Needles connect electrical stimulator manually stimulate evoke needle sensation every 10 min , total 4 time . The second set consist 14 needle place segmental abdominal point stimulate electrically : ST 27 bilaterally , CV6 connect CV10 ; leg point : SP10 connect non-acupuncture point locate 6 cun proximal patella medial border ( electrical stimulation ) , SP 6 liver ( LR ) 3 bilaterally ( manual stimulation ) . Extra segmental point pericardium ( PC ) 6 bilaterally ( manual stimulation ) . 2.1.2 Needle insertion technique Needle insertion gentle . Tighten skin press around area needle insertion gently insert needle . 2.1.3 Needles stimulation Needle size : 0.25 x 30 mm 0.30 x 40 0.30 x 50 mm . Select needle length respect patients'BMI : 0.25 x 30 mm needle woman normal BMI ; 0.30 x 40 mm needle overweight woman 0.30 x 50 75 mm needle obese woman . Depth insertion may vary patient patient . Needles place depth deep enough reach muscle/fibrous tissue . When needle insert , stimulate needle gently de qi ( needle sensation reflect activation sensory afferent ) . As soon de qi reach , make sure needle hurt cause pain discomfort . Manual stimulation needle attach electrical stimulator ( see ) stimulate insert , 10 minute , 20 minute immediately remove 30 minute . Attach electrodes accord protocol . Turn stimulator ( program 10 ) increase intensity . The intensity high possible without pain discomfort . The stimulation amplitude/intensity adjust 10 20 minute time needle stimulate manually manipulate . After 30 minute stimulator turn , electrode disconnect needle take . 2.1.4 Sham acupuncture protocol Disposable , single-use , sterilize needle make stainless steel , 0.20 x 20 mm ( Hwoto , Suzhou Medical Appliance Fact.215005 Suzhou , China ) insert superficially depth &lt; 5 mm , one shoulder upper arm non-acupuncture point . Placement needle unlikely affect ovulation IR woman PCOS . Electrodes attach needle stimulator turn intensity zero ( active current ) order mimic EA acupuncture protocol . No manual stimulation needle perform . An intended adjustment intensity 10 minute , 20 minute 30 minute stimulator turn needle remove . 2.1.5 True sham acupuncture treatment 1 . Time day acupuncturist name patient receive acupuncture record . 2 . The intensity stimulation ( mA ) note . It may vary different electrode . Note range e.g . 1.2 - 3.0 mA . 3 . Note event may affect treatment ( positive negative ) . 4 . Note concomitant medication . 5 . Collect menstrual log end every cycle . 2.2 Metformin placebo Metformin ( Kombiglyze XR ) placebo metformin pack tested commercial pharmacy supply company ( Squibb Company , Shanghai , China ) specifically study . Metformin placebo start 2 day baseline visit include OGTT . Subjects take 0.5 g/times , 3 time one day 6 cycle . 2.3 Monitoring examination treatment Physical examination perform monthly . Every menstruation record , include date , volume duration menstruation entire study follow-up . The condition physical exercise diet record every cycle . OGTT repeat third month treatment . 2.4 End treatment visit During end treatment visit baseline measure repeat list : 1 . Perform physical examination , include vital sign , height , weight , hip waist measurement well repeat hirsutism acne assessment end treatment pregnancy . 2 . Repeat serum level sex hormone steroid metabolic profile . 3 . Repeat transvaginal ultrasound ovarian morphology . 4 . Repeat OGTT . 5 . Collect 20ml blood , distribute store 10ml blood serum separation . Other 10ml blood determination DNA sphingolipid . 6 . Repeat QOL , sleeping , IPAQ anxiety/depression questionnaire , quantization table TCM . 7 . Collect menstrual log . 8 . Record adverse event concomitant medication . 9 . Answer two question acupuncture treatment . 2.5 Follow-up visit Baseline end treatment visit repeat 3 month last treatment ( see point 1-8 End treatment visit ) . All participant follow visit acupuncturists monthly 3 month . The condition physical exercise diet record every month . 2.6 Safety analysis Adverse event categorized percentage patient experience adverse event serious adverse event treatment period follow period document . Chi-square test perform examine difference proportion total category adverse event . 2.7 Statistics One sample Kolmogorov-Smirnov test use test normal distribution continuous variable . Continuous variable present mean ± standard deviation normally distribute median interquartile range normally distribute . Statistical comparison carry accord intention treat Student 's t-test , Mann-Whitney U-test , Wilcoxon sign rank test continuous variable χ2 test categorical variable appropriate . All statistical analysis data perform use SPSS program version 21.0 ( SPSS Inc. , Chicago , IL , USA ) , P-value &lt; 0.05 consider statistically significant .</detailed_description>
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Insulin Resistance</mesh_term>
	<mesh_term>Polycystic Ovary Syndrome</mesh_term>
	<mesh_term>Metformin</mesh_term>
	<criteria>1 . Chinese woman age 18 40 year . 2 . BMI ≥18.5kg/m2 . 3 . Confirmed diagnosis PCOS accord modify Rotterdam criterion 2003 include least two follow three feature : ①Oligo ( intermenstrual interval &gt; 35 day &lt; 8 cycle past year ) , amenorrhea ( intermenstrual interval &gt; 90 day ) and/or ; ② polycystic ovarian morphology , i.e . presence &gt; 12 antral follicle ( ≤ 9mm ) and/or ovarian volume &gt; 10 ml transvaginal scanning and/or ; ③clinical and/or biochemical hyperandrogenism . Clinical hyperandrogenism China Mainland define FerrimanGallwey ( FG ) score ≥5 ; biochemical hyperandrogenism total testosterone ( T ) &gt; 2.6 nmol/l free testosterone ≥6.0 pg/ml . 4 . Presence IR define homeostatic model assessment ( HOMAIR : [ fast insulin ( μU/mL ) × fast glucose ( mmol/L ) ] / 22.5 ) . A value ≥ 2.14 consider indicative IR . 5 . No immediate fertility wish willingness use barrier method contraception one year . 6 . Willingness sign consent form . 1 . Exclusion endocrine disorder : ① Uncorrected thyroid disease ( define TSH &lt; 0.2 mIU/mL &gt; 5.5 mIU/mL ) . A normal level within last year adequate entry . ② Poorly control Type I Type II diabetes ( define HbA1c level &gt; 7.0 % ) , patient receive antidiabetic medication insulin , thiazolidinediones , acarbose , sulfonylurea likely confound effect study medication ; Patients currently receive metformin XR ( extended release ) diagnosis Type I Type II diabetes PCOS alsoexcluded . Cushing 's syndrome ( define archetype MetS . High glucocorticoid level lead muscle , liver adipocyte insulin resistance . 17OHCS &gt; 55umol/24h UFC &gt; 304nmol/24h ) ④ Congenital adrenal hyperplasia ( define patient know 21hydroxylase deficiency enzyme deficiency lead phenotype congenital adrenal hyperplasia . 17OHP &gt; 10 ng/ml ACTH 124 h excited test ( 60 min ) ) ⑤ Suspected androgen secrete adrenal ovarian tumor . 2 . Use hormonal medication include Chinese Herbal prescription may affect outcome last 2 month . 3 . Receiving acupuncture past 2 month . 4 . Within 6 week pregnancy . 5 . Postabortion postpartum within past 6 week . 6 . Breastfeeding within last 4 month . 7 . Not willing give write consent study . 8 . Having bariatric surgery procedure within past 12 month period acute weight loss . 9 . Additional exclusion criterion include : Patients oral contraceptive , depot progestin , hormonal implant ( include Implanon ) . A two month washout period require prior screening patient agent . Longer washouts may necessary certain depot contraceptive form implant , especially implant still place . A onemonth washout require patient oral cyclic progestin . Heart disease ③ Patients history , suspect cervical carcinoma , endometrial carcinoma , breast carcinoma . Patients enrolled study require medication . ⑤ Patients take longer one month break protocol enrol .</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>40 Years</maximum_age>
	<verification_date>February 2016</verification_date>
	<keyword>polycystic ovary syndrome</keyword>
	<keyword>acupuncture</keyword>
	<keyword>insulin resistance</keyword>
	<keyword>HOMA-IR</keyword>
	<keyword>metformin</keyword>
</DOC>